Fresenius Medical Care to Exit China PD Business, Book €110M Q3 Charge
FMS is trading near its 52-week low of $20.02 (12% above the low).
Summary
Fresenius Medical Care announced a China portfolio optimization, exiting its PD business and discontinuing the 4008A system, with ~€110M in one-time Q3 2026 costs treated as a special item.
Key Events · Corporate Governance and Compliance · FMS
-
China Portfolio Optimization
The company is exiting its peritoneal dialysis business in China and discontinuing local production and sales of the 4008A hemodialysis system.
-
€110M One-Time Charge
A special item of approximately €110 million is expected in Q3 2026, primarily comprising impairment charges, scrappage, and termination costs.
-
Revenue Impact Limited
China represents 6-7% of Care Enablement segment revenues; the portfolio adjustment is not expected to meaningfully impact the future revenue outlook.
-
Leadership Appointment
Rex Liu has been appointed as market General Manager for China to lead the refined go-to-market strategy.
Analysis · FMS · Industrial Applications And Services
A restructuring of Fresenius Medical Care's China operations will see the company exit the peritoneal dialysis business and discontinue the 4008A hemodialysis system. The move is expected to trigger approximately €110 million in one-time costs in Q3 2026, treated as a special item. With China accounting for roughly 6-7% of Care Enablement segment revenue, the portfolio shift is material but not expected to meaningfully alter the segment's revenue outlook. To lead the refined strategy, the company has appointed Rex Liu as local General Manager, while doubling down on high-volume hemodiafiltration and critical care products.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FMS was trading at $22.42 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $11.9B. The 52-week trading range was $20.02 to $27.64. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.